BOLT (Bolt Biotherapeutics, Inc.) Short-Term Debt to Capital
This daily price chart for Bolt Biotherapeutics (BOLT) reflects metrics where the value is 0.37. Bolt Biotherapeutics generates revenue by creating immunostimulatory antibodies for oncology centers, expecting profits from licensing payments and insurance procurement. Efficiency is increasing through AI-driven automation of molecule screening, while the expansion of its base is driven by a partnership with Pfizer and strict FDA safety regulations for therapy.
Analytical breakdowns for Bolt Biotherapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Bolt Biotherapeutics|BOLT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Bolt Biotherapeutics|BOLT - Aggregate Debt Obligations|Debts to Book Capitalization Bolt Biotherapeutics Inc.|BOLT - Long-Term Debt Volume|Company Short-Term Debt Bolt Biotherapeutics|Quick Liquidity boltbio.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Bolt Biotherapeutics, Inc.
This ratio determines the proportion of liabilities maturing within one year relative to equity, serving as an indicator of current liquidity and credit risk. Analyzing the trend of short-term loans to equity allows for an assessment of the financial stability of Bolt Biotherapeutics (BOLT) during the recalibration of its R&D pipeline and the development of new antibody-conjugate platforms.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN: Short-Term Debt to Equity|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Equity ANAB|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Loans to Capital Ratio ENGN|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital JBIO|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|KYTX: Short-Term Debt to Equity|TLSA: Short-Term Debt to Capital|CABA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ventyx Biosciences|Current Liabilities to Capital theratech.com THTX|Short-Term Debt to Equity Ratio AVTX (Avalo Therapeutics)|Short-Term Loans to Capital Ratio ELDN|Short-Term Debt to Capital AGEN (Agenus Inc)|Ratio of Short-Term Indebtedness to Capital CLYM|Zura Bio - Short-Term Debt to Capital|Current Liabilities to Capital atyrpharma.com|adagene.com (ADAG) - Short-Term Debt to Equity|Ikena Oncology - Ratio of Short-Term Indebtedness to Capital|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Equillium Bio|Short-Term Debt to Equity Connect Biopharma (CNTB)|IMUX: Current Liabilities to Equity|Short-Term Debt to Capital ATRA (Atara Bio)|InflaRx NV (IFRX) - Current Liabilities to Capital|XFOR: Short-Term Debt to Equity Ratio|ACET - Short-Term Debt to Capital|CELU (celularity.com) - Short-Term Debt to Equity Ratio|INMB: Short-Term Loans to Capital Ratio|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Kezar Life Sciences Inc. (KZR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SABS|Short-Term Debt to Equity Ratio Akari Therapeutics, Plc AKTX|Short-Term Debt to Equity Enlivex Therapeutics Ltd. ENLV|Short-Term Debt to Capital Coefficient Q32 Bio Inc (QTTB)|GeoVax - Short-Term Debt to Capital|EDSA: Short-Term Debt to Equity|iBio Corp (IBIO) - Short-Term Debt to Equity|Current Liabilities to Capital Carisma Therapeutics Inc. (CARM)|Short-Term Debt to Equity XTL Biopharmaceuticals|Short-Term Debt to Equity HCWB|Short-Term Debt to Equity Ratio APVO (Aptevo Therapeutics)|Short-Term Loans to Capital Ratio AIM|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Current Liabilities to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD - Short-Term Debt to Capital Coefficient